wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34522789-2C6D094A-4490-413F-9EAD-0EA178D5427E
Q34522789-2C6D094A-4490-413F-9EAD-0EA178D5427E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34522789-2C6D094A-4490-413F-9EAD-0EA178D5427E
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia
P2860
Q34522789-2C6D094A-4490-413F-9EAD-0EA178D5427E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34522789-2C6D094A-4490-413F-9EAD-0EA178D5427E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
644cf0bc714b857ee9cded7451c9d3e0f34bcfb0
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.